Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Daslemia 70 mg Tablet
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$56.61 $47.56
Daslemia 70 mg Tablet is a targeted therapy designed to combat specific types of cancer, primarily chronic myeloid leukemia (CML), a malignancy that disrupts normal white blood cell production. The...
Dasatinib 70 mg
Active Pharmaceutical Ingredient
Daslemia 70 mg Tablet
$56.61
$47.56
Daslemia 70 mg Tablet is a targeted therapy designed to combat specific types of cancer, primarily chronic myeloid leukemia (CML), a malignancy that disrupts normal white blood cell production. The active ingredient, dasatinib, works by inhibiting certain proteins that promote cancer cell growth, thereby helping to slow or stop the progression of the disease. This medication is particularly beneficial for patients who are intolerant to other treatments or have developed resistance to them. It is essential to use Daslemia under the supervision of a healthcare professional due to potential side effects, including fluid retention and changes in blood cell counts. Regular monitoring is crucial to ensure safe and effective treatment outcomes. Patients should inform their doctors of any existing health conditions or medications they are taking to avoid adverse interactions. By targeting the underlying mechanisms of CML, Daslemia 70 mg Tablet represents a significant advancement in cancer therapy, offering hope for improved quality of life.
Active Pharmaceutical Ingredient
Uses
• Daslemia 70 mg tablet is primarily indicated for the treatment of chronic myeloid leukemia (CML). This condition affects the blood and bone marrow, leading to an overproduction of abnormal white blood cells. Patients may experience symptoms such as fatigue, weakness, and an enlarged spleen. By targeting the underlying mechanisms of CML, Daslemia helps manage these symptoms effectively.
• In addition to CML, Daslemia 70 mg tablet is also utilized in the management of acute lymphoblastic leukemia (ALL). This aggressive cancer originates in the bone marrow and disrupts normal blood cell production. Patients often present with symptoms like shortness of breath and frequent infections. Daslemia aids in controlling the proliferation of cancerous cells, thereby improving the overall health and well-being of individuals with ALL.
• Daslemia 70 mg tablet can be an essential part of a comprehensive treatment plan for patients with hematological malignancies. Its role in managing conditions such as CML and ALL makes it a valuable option for oncologists. By improving patient outcomes and alleviating symptoms, Daslemia contributes significantly to the therapeutic landscape of blood cancers. Regular monitoring and adjustments in treatment may enhance the efficacy of Daslemia in achieving better health results.
• For patients diagnosed with CML or ALL, Daslemia 70 mg tablet may serve as a cornerstone of therapy. Its targeted action helps to reduce the burden of disease and enhance quality of life. Physicians may prescribe Daslemia as part of a multi-faceted approach to cancer care, integrating it with other treatments as needed. This collaborative treatment strategy helps ensure that patients receive comprehensive care tailored to their specific needs.
Benefits
Daslemia 70 mg Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Daslemia Tablet is usually taken once a day, which may be more convenient for some people compared to other treatments. Anti-cancer Drug Daslemia is effective in people with CML or ALL who have not responded to other treatments.
Side Effects
Daslemia 70 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Fever
• Nausea
• Vomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
Common Side Effects
• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
How To Use
Daslemia 70 mg Pack may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Dasatinib Tablet 70 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Dasatinib Tablet 70 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Anti-cancer Drug Daslemia should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Daslemia 70 mg. Daslemia 70 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Dasatinib Tablet 70 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dasatinib Tablet 70 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Daslemia 70 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Daslemia 70 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Daslemia Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Daslemia 70 mg Pack during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Daslemia 70 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Daslemia 70 mg.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.